Development of a novel senolytic by precise disruption of FOXO4-p53 complex

Código QR

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

Guardado en:

Detalles Bibliográficos
Autores principales:	Utkarsh Tripathi, Selim Chaib, Erin O. Wissler Gerdes, Kelly A. Hogan, Yi Zhu
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9698103bb31544af869c9b22aaf4db31
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Alexandra Maximova, et al.
Publicado: (2021)

Identification of HSP90 inhibitors as a novel class of senolytics
por: Heike Fuhrmann-Stroissnigg, et al.
Publicado: (2017)

A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
por: Leleesha Samaraweera, et al.
Publicado: (2017)

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
por: Jing Zhao, et al.
Publicado: (2021)

Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Songhyun Lim, et al.
Publicado: (2021)

Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Francisco Triana-Martínez, et al.
Publicado: (2019)

Evaluating the neuroprotective impact of senolytic drugs on human vision
por: Nevin W. El-Nimri, et al.
Publicado: (2020)

Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Francisco Triana-Martínez, et al.
Publicado: (2020)

Novel p53 therapies for head and neck cancer
por: Mario R. Castellanos, et al.
Publicado: (2016)

Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo A, et al.
Publicado: (2018)

Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence
por: Elena Zoico, et al.
Publicado: (2021)

An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression.
por: Matt Lam, et al.
Publicado: (2012)

Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells
por: Tapas Patra, et al.
Publicado: (2021)

Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R
por: Jonathan K. Mitchell, et al.
Publicado: (2017)

Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
por: Elisabeth Silden, et al.
Publicado: (2013)

Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
por: Jasper Iske, et al.
Publicado: (2020)

<i>In Silico</i> Assessment and Molecular Docking Studies of Some Phyto-Triterpenoid for Potential Disruption of Mortalin-p53 Interaction
por: Minh Quan Pham, et al.
Publicado: (2021)

Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice
por: Yueying Zhou, et al.
Publicado: (2021)

Enhancement of Bone-Forming Ability on Beta-Tricalcium Phosphate by Modulating Cellular Senescence Mechanisms Using Senolytics
por: Xinchen Wang, et al.
Publicado: (2021)

Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
por: Yonghan He, et al.
Publicado: (2020)

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
por: Li Ren Kong, et al.
Publicado: (2020)

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Sarah E. Woodfield, et al.
Publicado: (2021)

Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers
por: R. Kumar, et al.
Publicado: (2018)

Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
por: Emanuel J. Novais, et al.
Publicado: (2021)

FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms.
por: Jeremy A Sullivan, et al.
Publicado: (2012)

The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
por: Cecilia B Levandowski, et al.
Publicado: (2021)

SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.
por: Cian J Lynch, et al.
Publicado: (2010)

p53 e as hemopatias malignas
por: Geraldo Barroso Cavalcanti Júnior, et al.
Publicado: (2002)

Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
por: Tamara Isermann, et al.
Publicado: (2021)

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Marcus J. G. W. Ladds, et al.
Publicado: (2018)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Sarah E. Woodfield, et al.
Publicado: (2021)

FOXO3a and Its Regulators in Prostate Cancer
por: Dominika Ewa Habrowska-Górczyńska, et al.
Publicado: (2021)

Development of a novel immunoassay to detect interactions with the transactivation domain of p53: application to screening of new drugs
por: Yufeng Xiong, et al.
Publicado: (2017)

A novel ATM/TP53/p21-mediated checkpoint only activated by chronic γ-irradiation.
por: Lili Cao, et al.
Publicado: (2014)

Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex
por: Carolin Sailer, et al.
Publicado: (2018)

Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B.
por: Emil Kofod-Olsen, et al.
Publicado: (2013)

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Marcus J. G. W. Ladds, et al.
Publicado: (2018)

Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties
por: Mizuho Nakayama, et al.
Publicado: (2020)

Polimorfismos de p53 y enfermedad coronaria
por: Verdejo,Hugo
Publicado: (2009)

Structure of the p53/RNA polymerase II assembly
por: Shu-Hao Liou, et al.
Publicado: (2021)